Bruno Paiva

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

S. Vincent Rajkumar, Meletios Α. Dimopoulos, Antonio Palumbo et al. · The Lancet Oncology · 2014 · 4.7K citations · Full text

Hematological Malignancy, Medicine, Hematology +7

Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

Juan Flores‐Montero, Luzalba Sanoja-Flores, Bruno Paiva et al. · Leukemia · 2017 · 626 citations · Full text

Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma

María‐Victoria Mateos, Miguel‐Teodoro Hernández, Pilar Giraldo et al. · New England Journal of Medicine · 2013 · 569 citations · Full text

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

Bruno Paiva, María‐Belén Vídriales, Jorge Cerveró et al. · Blood · 2008 · 463 citations · Full text

Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial

María‐Victoria Mateos, Albert Oriol, Joaquín Martínez‐López et al. · The Lancet Oncology · 2010 · 459 citations

Hematological Malignancy, Elderly Patients, Medicine +7